GET THE APP

..

Journal of Blood & Lymph

ISSN: 2165-7831

Open Access

Evaluation of Preoperative Fibrinogen/Albumin Ratio and Carcinoembryonic Antigen: A New Prognostic Marker in Gastric Cancer

Abstract

Musluh Hakseven*, Özhan Çetindağ, Gökhan Avşar, R?za Deryol, Cem Azılı, Gözde Sırgancı, Serdar Culcu, Serkan Akbulut and Ali Ekrem Ünal

Introduction: Gastric Cancer (GC) is one of the most common cancers that can result in death. Markers are needed to detect gastric cancer early and manage treatment. We aimed to reveal the relationship between Carcinoembryonic Antigen (CEA) level and Fibrinogen-Albumin Ratio (FAR) and prognosis in gastric cancer, as well as to examine the relationship of these values with the number of metastatic lymph nodes and TNM stage.

Materials and methods: The data of 805 consecutive gastrectomy patients were analyzed retrospectively. A total of 461 patients were included. The optimal cut- off values of CEA and FAR were 2.43 ng/mL and 1.26, respectively. Patients were stratified into three groups based on this cutoff value: CEA-FAR=0 (CEA<2.43 ng/mL and FAR<1.26), CEA-FAR=1 (CEA ≥ 2.43 ng/mL or FAR ≥ 1.26), and CEA-FAR=2 (CEA ≥ 2.43 ng/mL and FAR ≥ 00201.26).

Results: There was a significant relationship between high CEA and stage (p=0.040), N status (p=0.017), and lymph node metastasis (p=0.004), and also there was a significant correlation between high FAR value and grade (p=0.003), stage (p<0.001), T status (p<0.001), N status (p<0.001) and metastatic lymph node count (p<0.001). Overall and disease-free survival were significantly different between the three CEA-FAR groups.

Conclusion: We believe that pre-operative FAR and CEA values are independent predictors of survival. FAR and CEA are potential prognostic indicators for resectable gastric cancer due to their easy access and low cost. Considering survival and prognosis in patients with very high preoperative CEA and FAR values, neoadjuvant chemotherapy should also be considered.

HTML PDF

Share this article

Google Scholar citation report
Citations: 443

Journal of Blood & Lymph received 443 citations as per Google Scholar report

Journal of Blood & Lymph peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward